158 related articles for article (PubMed ID: 30620279)
1. Serum lysosomal-associated membrane protein-2 levels are increased in small and medium-vessel vasculitis, especially in polyarteritis nodosa.
Li N; Zhu B; Zhu Q; Heizati M; Wu T; Wang G; Yao X; Luo Q; Liu S; Liu S
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):79-85. PubMed ID: 30620279
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal-associated membrane protein-2 plays an important role in the pathogenesis of primary cutaneous vasculitis.
Takeuchi S; Kimura S; Soma Y; Waki M; Yamaguchi M; Nakazawa D; Tomaru U; Ishizu A; Kawakami T
Rheumatology (Oxford); 2013 Sep; 52(9):1592-8. PubMed ID: 23704322
[TBL] [Abstract][Full Text] [Related]
3. Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis.
Zhu B; Li N; Zhu Q; Wu T; Heizati M; Wang G; Yao X; Luo Q; Liu S; Liu S; Hong J
Medicine (Baltimore); 2019 Feb; 98(6):e14493. PubMed ID: 30732222
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Against Lysosome Associated Membrane Protein-2 (LAMP-2) in Pediatric Chronic Primary Systemic Vasculitis.
Gibson KM; Kain R; Luqmani RA; Ross CJ; Cabral DA; Brown KL
Front Immunol; 2020; 11():624758. PubMed ID: 33613565
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-lysosomal-associated membrane protein-2 antibody levels in cutaneous polyarteritis nodosa.
Kawakami T; Ishizu A; Arimura Y; Soma Y
Acta Derm Venereol; 2013 Jan; 93(1):70-3. PubMed ID: 22854803
[TBL] [Abstract][Full Text] [Related]
6. The Association of Serum Anti-Lysosomal-Associated Membrane Protein-2 Antibody with Vasculitis Combined with Hypertension.
Zhu B; Cai X; Zhu Q; Wu T; Liu S; Liu S; Hong J; Li N
Int J Hypertens; 2022; 2022():9656560. PubMed ID: 35356030
[TBL] [Abstract][Full Text] [Related]
7. Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
Kawakami T; Takeuchi S; Arimura Y; Soma Y
Br J Dermatol; 2012 Jun; 166(6):1206-12. PubMed ID: 22309950
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?
Baranger TA; Audrain MA; Testa A; Besnier D; Guillevin L; Esnault VL
Autoimmunity; 1995; 20(1):33-7. PubMed ID: 7578859
[TBL] [Abstract][Full Text] [Related]
9. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
[No Abstract] [Full Text] [Related]
10. Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis.
Maruyama H; Hirayama K; Nagai M; Ebihara I; Shimohata H; Kobayashi M
Clin Rheumatol; 2016 Oct; 35(10):2469-76. PubMed ID: 27251675
[TBL] [Abstract][Full Text] [Related]
11. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
Chen M; Wang F; Zhao MH
Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
[TBL] [Abstract][Full Text] [Related]
12. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
[TBL] [Abstract][Full Text] [Related]
13. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
[TBL] [Abstract][Full Text] [Related]
14. Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wang H; Sha LL; Ma TT; Zhang LX; Chen M; Zhao MH
PLoS One; 2016; 11(2):e0148197. PubMed ID: 26840412
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
Yoon T; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):116-121. PubMed ID: 30873951
[TBL] [Abstract][Full Text] [Related]
16. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
17. Comparison of characteristics of muscle magnetic resonance imaging findings in patients with antineutrophilic cytoplasmic antibody-associated vasculitis and polyarteritis nodosa.
Ito H; Yoshida K; Fukuda T; Noda K; Ukichi T; Kurosaka D
Int J Rheum Dis; 2024 Mar; 27(3):e15116. PubMed ID: 38519426
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis.
Watanabe S; Gono T; Nishina K; Sugitani N; Watanabe E; Yabe H; Terai C
BMC Immunol; 2017 Dec; 18(1):53. PubMed ID: 29262790
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2019 Jun; 38(6):1685-1690. PubMed ID: 30863949
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
